TOP TIERMARKET NEWSWIRE
News & sentiment

TARSUS PHARMACEUTICA (TARS) — News & AI sentiment

TARSUS PHARMACEUTICA (TARS) news roundup. 13 stories aggregated over the last 30 days. Average 30-day sentiment is 53.7/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 4 sales totalling $2.5M — net selling of $2.5M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
13
avg sentiment 53.7/100
Insider net (90d)
$2.5M
0 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on TARS

Jul 24
Guggenheim cuts Tarsus Pharmaceuticals stock price target to $89
Investing.com Analyst Ratings34 · bearishanalyst
Jul 21
Jul 13
Jul 13
Jul 13
Jul 13
Jul 11
Jul 9
Jul 9
Jul 8
Jul 8
Jul 8
Jul 8
Jun 29
Jun 29
Jun 19
May 28
May 15
May 7
Open TARS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →